CommentFinal results from a pivotal phase 3 malaria vaccine trial
References (5)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
Lancet
(2015)First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children
N Engl J Med
(2011)
There are more references available in the full text version of this article.
Cited by (9)
Antimalarial, Antioxidant, and Toxicological Evaluation of Extracts of Celtis africana, Grosseria vignei, Physalis micrantha, and Stachytarpheta angustifolia
2021, Biochemistry Research InternationalA protocol for systematic review and meta-analysis of optimizing treatment for malaria
2020, Medicine (United States)Virus-like particle-mediated intracellular delivery for nanomedicine
2017, Nanotechnology in Biology and Medicine: Methods, Devices, and Applications, Second Edition
Copyright © 2015 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd. All rights reserved.